Insulin in Diabetes Management: Effective Patient Selection Is Key

Slides:

Advertisements

Similar presentations

What's New in Basal Insulin for Diabetes

Advertisements

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.

Short-, Intermediate-, Long-Acting Insulins

Diabetic Dyslipidemia in Practice

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Applying Data to Practice

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

Special Consideration in Insulin Therapy

Advances in Managing Inhibitors in Patients With Hemophilia A

Updates on Emerging GLP-1 Receptor Agonists

New Patient-Friendly Options for Managing Insulin Dosing

Overview of Disparities

Progression After Cancer Immunotherapy in Advanced NSCLC

Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.

Modern Strategies for Basal Insulin Use in T2D

Patient Case Discussions in T2D: What Intensification Plan Is Best?

Epilepsy Treatment Across the Spectrum

Updates on Outcomes for Novel T2D Therapies

How Early Should Basal Insulin Be Used in T2D Management?

Examining CV Effects of Basal Insulin Therapy

What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?

Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.

Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

Emerging Basal Insulins for Diabetes

Need to Know! Screening and Diagnosis of Kidney Disease in Diabetes

Precision Management of RA and Comorbidities

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

Seizures in the Elderly: Treatment and Special Considerations

Integrated Diabetes Care: How Can We Make the Best Use of New Technology?

Novel Basal Insulin Formulations in the Modern Era of T2D Management

A Primer on Medication Delivery Systems in COPD Management

Charting Progress in MS Treatment:

Injectable Options as Add-Ons to Basal Insulin: Targeting PPG in Type 2 Diabetes Patients.

Diagnosing Focal Epilepsy: A Clinical Case

New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.

Translating the Latest and Greatest Advances in PAH Into Clinical Practice.

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Learning Objectives Metabolic Abnormalities Associated With T2D.

Program Overview. Major Depressive Disorder: The Challenging Patient and the Goal of Recovery.

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

Combining Efforts for Older Drivers: Licensing Agencies, Occupational Therapists, and Clinicians.

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

When to Start and What to Use

A Primer on Medication Delivery Systems in COPD Management

Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.

Challenges in Severe Asthma

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

Patient Questions and Expert Answers in Psoriasis:

A Guideline-Based Approach to HCV Care

Optimizing Joint Health in Hemophilia

Critical Decision Points in Insomnia

Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial

Add-On Therapy to Insulin in T1DM Management

Hypoglycemia Is BAD.

Improving Effective Basal Insulin Use in Clinical Practice

Improving Overall Health

Program Goal. Program Goal Disclaimer Overview.

Getting PPG Under Control

Case Studies in Peanut Allergy Immunotherapy

Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors.

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.

Fixed-Ratio Combination Therapy in T2DM

Expert Perspectives.

An insulin simplification regimen: from multiple injections to once-daily long-acting (basal) insulin plus noninsulin agents. *Basal insulins: glargine.

Emerging Basal Insulins for Diabetes

Fresh perspectives ON BASAL Insulins in diabetes care

Motor Fluctuations in PD

Presentation transcript:

Insulin in Diabetes Management: Effective Patient Selection Is Key

Case 1 History and Labs

Case 1 Treatment Considerations

Case 1 Common Patient Concerns With Insulin

Insulin

Basal Insulins

Case 1 Regimen Simplification

Metformin Use

Insulin Glargine Not Associated With Increased Risk for CV Events

Overcoming Barriers to Insulin Initiation

Overcoming Barriers to Insulin Initiation (cont)

Instructing Patients on Insulin Use

Case 2 History and Labs

Case 2 Treatment Considerations

Newer Insulin Options Glargine U300 and Degludec

Case 2 Switching Insulins

Concluding Remarks

Abbreviations